These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1050 related articles for article (PubMed ID: 9263149)
21. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748 [TBL] [Abstract][Full Text] [Related]
22. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Delgado Alves J; Kumar S; Isenberg DA Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551 [TBL] [Abstract][Full Text] [Related]
23. The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. Cabral AR; Amigo MC; Cabiedes J; Alarcon-Segovia D Am J Med; 1996 Nov; 101(5):472-81. PubMed ID: 8948270 [TBL] [Abstract][Full Text] [Related]
24. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048 [TBL] [Abstract][Full Text] [Related]
26. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome. Hanly JG; Smith SA J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227 [TBL] [Abstract][Full Text] [Related]
27. Combined search for anti-beta2-glycoprotein I and anticardiolipin antibodies in antiphospholipid syndrome: contribution to diagnosis. Sanmarco M; Roll P; Gayet S; Oksman F; Johanet C; Escande A; Cohen JH; Chevailler A; Goetz J; Humbel RL; Sibilia J J Lab Clin Med; 2004 Sep; 144(3):141-7. PubMed ID: 15454883 [TBL] [Abstract][Full Text] [Related]
28. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome]. Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784 [TBL] [Abstract][Full Text] [Related]
29. Association of antimitochondrial antibodies type 5 and anti-beta 2 glycoprotein I antibodies in the antiphospholipid syndrome. Laperche S; Abuaf N; Meyer O; Carsique R; Deschamps A; Rajoely B; Johanet C; Homberg JC J Rheumatol; 1994 Sep; 21(9):1678-83. PubMed ID: 7799349 [TBL] [Abstract][Full Text] [Related]
30. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations. Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986 [TBL] [Abstract][Full Text] [Related]
31. [Antiphospholipid antibodies: clinical significance and biological diagnosis]. Arnoux D; Boutière B; Sanmarco M Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099 [TBL] [Abstract][Full Text] [Related]
32. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252 [TBL] [Abstract][Full Text] [Related]
33. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome. Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267 [TBL] [Abstract][Full Text] [Related]
34. [Antiphospholipid syndrome and stroke]. Kitagawa Y Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [TBL] [Abstract][Full Text] [Related]
35. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
36. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792 [TBL] [Abstract][Full Text] [Related]
37. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases. Merkel PA; Chang Y; Pierangeli SS; Harris EN; Polisson RP J Rheumatol; 1999 Mar; 26(3):591-6. PubMed ID: 10090168 [TBL] [Abstract][Full Text] [Related]
38. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome. Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952 [TBL] [Abstract][Full Text] [Related]
39. Clinical significance of phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies in systemic lupus erythematosus. Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y Lupus; 1995 Dec; 4(6):472-6. PubMed ID: 8749570 [TBL] [Abstract][Full Text] [Related]
40. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]